Evidence mapPaperPMID 25412152Full record

ReviewNutrients2014

Obesity: pathophysiology and intervention.

Yi Zhang, Ju Liu, Jianliang Yao, Gang Ji, Long Qian, Jing Wang, Guansheng Zhang, Jie Tian, Yongzhan Nie, Yi Edi Zhang and 2 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06132477 (Biometabolic Impact of Continuation of GLP-1 Agonists Following Bariatric), which is not on this map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06132477 phase4recruitingstarted 2024, after this paper: background citation

Biometabolic Impact of Continuation of GLP-1 Agonists Following Bariatric

Ran2024Enrolled150Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus, Hypertension, Metabolic Syndrome, Morbid ObesityArmsGLP-1 receptor agonist
Open the trial in the graph
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Interaction between anNutrients · 2018
    Trial
  8. Article
  9. The role of PYY in improving insulin resistance.Frontiers in endocrinology · 2026
    Review
  10. Review
  11. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  12. Review
  13. Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Anti-Obesity Effects ofFood science & nutrition · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yi ZhangSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. zhangyi@life.xidian.edu.cn.
Ju LiuSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. liuju@life.xidian.edu.cn.
Jianliang YaoSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. yaojianliang@life.xidian.edu.cn.
Gang JiXijing Gastrointestinal Hospital, the Fourth Military Medical University, Xi'an, Shaanxi 710032, China. jigang@fmmu.edu.cn.
Long QianDepartment of Biomedical Engineering, Peking University, Beijing 100871, China. qianlong2008@yeah.net.
Jing WangSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. wangjingwroolafd@163.com.
Guansheng ZhangSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. zhangguansheng66@126.com.
Jie TianSchool of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China. tian@ieee.org.
Yongzhan NieXijing Gastrointestinal Hospital, the Fourth Military Medical University, Xi'an, Shaanxi 710032, China. nieyongzhan@gmail.com.
Yi Edi ZhangDepartment of Psychiatry & McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL 32610, USA. zhangyi@life.xidian.edu.cn.
Mark S GoldDepartment of Psychiatry & McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL 32610, USA. msgold@ufl.edu.
Yijun LiuDepartment of Psychiatry & McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL 32610, USA. yijunliu@ufl.edu.
Xidian University · CNAir Force Medical University · CNPeking University · CNUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity presents a major health hazard of the 21st century. It promotes co-morbid diseases such as heart disease, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis. Excessive energy intake, physical inactivity, and genetic susceptibility are main causal factors for obesity, while gene mutations, endocrine disorders, medication, or psychiatric illnesses may be underlying causes in some cases. The development and maintenance of obesity may involve central pathophysiological mechanisms such as impaired brain circuit regulation and neuroendocrine hormone dysfunction. Dieting and physical exercise offer the mainstays of obesity treatment, and anti-obesity drugs may be taken in conjunction to reduce appetite or fat absorption. Bariatric surgeries may be performed in overtly obese patients to lessen stomach volume and nutrient absorption, and induce faster satiety. This review provides a summary of literature on the pathophysiological studies of obesity and discusses relevant therapeutic strategies for managing obesity.

Indexed as

Anti-Obesity AgentsBariatric SurgeryBulimiaComorbidityCravingDiabetes Mellitus, Type 2Gastrointestinal HormonesHeart DiseasesHumansObesitySleep Apnea, ObstructiveAnti-Obesity AgentsGastrointestinal Hormones

Identifiers

PMID25412152
PMCPMC4245585
OpenAlexW2087702881

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.